call our support:
+31 20 8084 414
  • Sign In
  • Create an Account
Toggle Nav
My Cart
Search
Advanced Search
Menu
Account

Spinraza (nusinersen)

€108,100.00
In stock
SKU
Spinraza (nusinersen)

How to buy Spinraza (nusinersen): You can order Spinraza (nusinersen) from TheSocialMedwork if the drug has not been approved or is not available in your country. We help patients and doctors get access to medicines at the lowest price worldwide.

Neurology Spinal Muscular Atrophy
Marketing Authorisation Holder Biogen Idec Ltd
Mode of Action Antisense oligonucleotide (ASO)
Administration intrathecal injection
Regulatory agency approval European Medical Agency (EMA), European Union, Food and Drug Administration (FDA), USA, Therapeutic Goods Administration (TGA), Australia
Strength 2.4 milligram / millilitre
Package 1 vial of 12mg/ 5 ml - Vials
Loading...

What is Spinraza (nusinersen) for?

Spinraza (nusinersen) is indicated for the treatment of pediatric and adult patients with spinal muscular atrophy (SMA)1,4. 

How does Spinraza (nusinersen) work?

SMA is a rare and often fatal hereditary (genetic) disease that causes weakness and muscle wasting due to the loss of motor neurons controlling movement2. 

Spinraza (nusinersen) is an antisense oligonucleotide (ASO) that is designed to treat SMA caused by mutations in the chromosome 5q. This mutation leads to the deficiency of a protein, the survival motor neuron (SMN) protein. Spinraza (nusinersen) alters the synthesis of the deficient protein in order to increase production of full-length SMN protein and thereby promoting the maintenance of motor neurons3.

Is Spinraza (nusinersen) approved?

Spinraza (nusinersen) was approved for the treatment of children and adults with spinal muscular atrophy (SMA) by:

  • FDA (USA) on December 23, 20162
  • EMA (EU) on May 30, 20175

How do I take Spinraza (nusinersen)?

Spinraza is an injection administered into the fluid surrounding the spinal cord (intrathecal injection)2,5. The standard dosage is:

  • 12 mg / 5 mL per administration

Initiate treatment with 4 loading doses. The first dose should be followed by 3 more doses after 2, 4, and 9 weeks and then one dose every 4 months thereafter. Treatment should be continued for as long as the patient benefits from it1,5.

Complete information about Spinraza (nusinersen) dosage and administration can be found in the resources section. 

Consult your treating doctor for personalised dosing.

Common side effects of Spinraza (nusinersen)

Side effects include4:
  • back pain
  • headache
  • vomiting.
For a comprehensive list of side effects and adverse reactions please refer to the official prescribing information1,4.
More Information
Working ingredient Nusinersen
Shipping method Cold chain (temperature controlled)
Package 1 vial of 12mg/ 5 ml -
Therapeutic Area Neurology
Neurology Spinal Muscular Atrophy
Indication Spinal Muscular Atrophy (SMA)
Administration intrathecal injection
Mode of Action Antisense oligonucleotide (ASO)
Strength 2.4
Regulatory agency approval European Medical Agency (EMA), European Union, Food and Drug Administration (FDA), USA, Therapeutic Goods Administration (TGA), Australia
Marketing Authorisation Holder Biogen Idec Ltd
HS Code N/A
CAS Number N/A
The efficacy of nusinersen for SMA was assessed in a clinical trial (CS3B - ENDEAR) involving 121 patients with infantile-onset SMA who were diagnosed before 6 months of age and who were less than 7 months old at the time of their first dose1,4. Patients were randomised to receive an injection of Spinraza (nusinersen) into the fluid surrounding the spinal cord, or undergo a mock procedure (sham-control) without drug injection (a skin prick)1,4. 

At the final analysis, the percentage of responders (patients achieving the pre-defined motor milestone responder criteria) among the nusinersen group was 51% vs 0%  among the patients in the control group. Fewer patients died or received permanent ventilation among the nusinersen treated patients (39%) compared with the control group (68%)4. The portion of patients that achieved improvement in total milestone score (which included the ability to kick, head control, rolling, sitting, crawling, standing or walking) was 67% in the patients treated with nusinersen vs 17% in the sham-control group, while the portion of patients that worsened in the two groups was 1% and 22% respectively4. When measured with the Children’s Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP INTEND) score, the proportion of patients achieving a 4-point improvement was 73% with nusinersen and 3 % without, while the proportion of those worsening was 7% with nusinersen and 49% without4.

Positive results were achieved also in a study on patients with later onset SMA (after 6 months of age). The study CS4 (CHERISH) involved 126 patients randomised 2:1 to either nusinersen or sham-control. The main measure considered was the Hammersmith Functional Motor Scale Expanded (HFMSE). Among the patients treated with nusinersen, 57.3% achieved an improvement from baseline of at least 3 points vs. 20.5% of the patients in the control group4.

1. Summary of Product Characteristics [FDA]: Spinraza (nusinersen) [PDF]
    Biogen, Dec 2016. 

2. FDA approves first drug for spinal muscular atrophy
    FDA, Dec 2016.

3. FDA Approves Biogen’s SPINRAZA™ (nusinersen), The First Treatment for Spinal Muscular Atrophy
    Biogen, Dec 2016. 

4. Summary of Product Characteristics [EMA]: Spinraza (nusinersen) [PDF]
    Biogen, June 2017. 

5. Human Medicines: Spinraza (nusinersen)
    cited Oct 2017

Shipping Type Cold Chain
Shipping method Cold chain (temperature controlled)
Dynamic Weight No
100% legal and regulated
Registered with the Dutch Ministry of Health as an independent intermediary.

 

Registration number 6730 BEM
Secured logistics globally
• Standard and express delivery (DHL or UPS)
• 24/7 track & trace delivery
• Temperature regulated shipping
Secure payments
All payments are handled securely and are SSL encrypted.
We accept:
Bank transfer & Credit card

 

5.0
22 reviews

Patient reviews

 Tomasz Maćkowiak

During the transaction process I was very well informed by the TheSocialMedwork team. They have put as much of their effort to offer best service to me. Moreover the medicine I have ordered was imported two weeks earlier then it was expected. I highly recommend The Social Med Work.

Patient reviews

 Emina Mušović

Thank you for the wonderful cooperation! It's very reserved of us to say we're pleased because you really resolved all our doubts. The medicine has now arrived and we hope it helps. We know we were difficult, with the million different questions but well... That's all behind us now. Strongly recommended! :)

5.0
22 reviews

Patient reviews

 Mohamed Rahmat

I am fully satisfied with your online support service. Happy to deal with you.. fast & very fast support.. did not have to wait even 5 minutes! THANK YOU MEDWORK

Questions our patients are asking

visit our support page
You always need a prescription from a doctor based in your country. Other documents, such as an import license from the Ministry of Health, may be needed and depend on your country’s regulations. Contact us and we will provide you with all of the information about the required documents needed for your country.
For prescription medicines you will always need a prescription from your treating doctor. This is to ensure that your treatment is monitored and led by a doctor who is responsible for administering the medicine to you. The prescription is the evidence that your doctor gives you their medical support.
Your order will be shipped to you by our partner couriers, such as DHL, UPS and specialised medicine couriers. If you want us to use a specific courier please inform us when you place your order.
Yes. TheSocialMedwork is registered with the Dutch Ministry of Health as an independent medicines intermediary (registration number 6730 BEM). We always follow your country’s laws and regulations and will discuss any legal requirements with you. We only ship medicines when our patients have a prescription from their treating doctor.
By using TheSocialMedwork you will receive genuine medicines in perfect condition, no matter where you live.
Yes, you are welcome to visit us. We are located in the city centre of Amsterdam at the Herengracht 480. Contact us to schedule the best time for your visit.

 

How can we help you?

We're ready to answer any question!

Our Support team is available between
9:00–18:00 Central European Time, Monday to Friday.

 

Don't speak English? We also speak
Afrikaans, Armenian, Bosnian, Bulgarian, Dutch, French, German, Italian, Lithuanian, Mandarin, Polish, Portuguese, Russian, Serbian, Slovenian, Spanish and Turkish

 

Speak a different language?
Send us a message and we’ll do our best to translate.

 

Our guarantee: We will reply to all messages within 2 hours during office hours.

 

If you want to reach us via phone or chat, please visit our contact page

 

Totally awesome!
Keep up the great
work you’re doing!

Dee Penfold - December 3, 2016
On TheSocialMedwork Facebook

Need a medicine that’s not
approved in your country?

We help patients, physicians and pharmacists acquire the latest life-changing medicines. Not available in your country? No problem - as long as it's approved by a reputable medical authority somewhere, we can help! Contact us today and our experienced team of qualified pharmacists and industry professionals will help you.
learn more
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Medicine information contained herein may be time sensitive. The absence of a warning for a given medicine or combination thereof in no way should be construed to indicate that the medicine or combination is safe, effective or appropriate for any given patient. Always consult your treating physician before starting a course of treatment.